Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India.
Molecular Biology Lab, Centre for Cellular and Molecular Research, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India.
Arch Oral Biol. 2025 Jan;169:106090. doi: 10.1016/j.archoralbio.2024.106090. Epub 2024 Sep 12.
This study aimed to investigate the role of a novel m6A and cell cycle regulator YWHAG in oral squamous cell carcinoma (OSCC) by analyzing its expression and functional implications.
Tumor samples (n = 51) and adjacent non-tumor samples (n = 38) were collected from patients with OSCC, and cell lines were processed. YWHAG mRNA expression was assessed using quantitative reverse transcription PCR (RT-qPCR) analysis. Various tools, such as UALCAN, Protein-Atlas analysis, TIMER 2.0, and other in silico tools, were used to explore clinicopathological correlations, protein expression, immune cell infiltration, and functional associations of YWHAG.
YWHAG mRNA and protein expression were significantly upregulated in OSCC tumor tissues and OSCC cell lines compared to non-tumor tissues and normal cells (p < 0.001). High YWHAG expression significantly correlated with advanced tumor stage, higher grade, lymph node metastasis, and poor prognosis (p < 0.05). Functional analysis revealed that YWHAG is associated with pathways involved in aggressive cancer progression. YWHAG expression positively correlated with its target gene CTTN expression, which was also upregulated in OSCC and associated with poor prognosis (p < 0.05).
Study findings indicate that YWHAG may contribute to the progression of OSCC and could be a potential therapeutic target or prognostic biomarker. Further investigation is necessary to understand the underlying mechanisms and assess the clinical implications of YWHAG dysregulation in OSCC.
本研究旨在通过分析新型 m6A 和细胞周期调控因子 YWHAG 的表达及其功能意义,探讨其在口腔鳞状细胞癌(OSCC)中的作用。
收集 51 例 OSCC 患者的肿瘤样本(n=51)和相邻非肿瘤样本(n=38),以及处理细胞系。采用定量逆转录 PCR(RT-qPCR)分析评估 YWHAG mRNA 表达。使用 UALCAN、Protein-Atlas 分析、TIMER 2.0 和其他计算工具,探索 YWHAG 的临床病理相关性、蛋白表达、免疫细胞浸润和功能关联。
与非肿瘤组织和正常细胞相比,OSCC 肿瘤组织和 OSCC 细胞系中 YWHAG mRNA 和蛋白表达显著上调(p<0.001)。高 YWHAG 表达与晚期肿瘤分期、高级别、淋巴结转移和不良预后显著相关(p<0.05)。功能分析表明,YWHAG 与涉及侵袭性癌症进展的途径相关。YWHAG 表达与 YWHAG 靶基因 CTTN 的表达呈正相关,CTTN 在 OSCC 中也上调,并与不良预后相关(p<0.05)。
研究结果表明,YWHAG 可能促进 OSCC 的进展,可能成为潜在的治疗靶点或预后生物标志物。需要进一步研究以了解 YWHAG 失调在 OSCC 中的潜在机制及其临床意义。